Positive airway pressure (PAP) is the treatment of choice for patients with moderate-to-
severe obstructive sleep apnea (OSA). Randomized controlled trials have demonstrated that …

Data from animal and human studies provide a biological plausibility to the notion that
obstructive sleep apnea activates pathways that lead to insulin resistance, atherosclerosis …

Abstract Study Objective: To determine the neurocognitive effects of continuous positive
airway pressure (CPAP) therapy on patients with obstructive sleep apnea (OSA). Design …

Obstructive sleep apnea is a chronic illness with increasing prevalence. In addition to
associated cardiovascular comorbidities, obstructive sleep apnea syndrome has been …

Rationale and objectives Impaired insulin sensitivity (ISx), increased visceral abdominal fat
(VAF) and liver fat are all central components of the metabolic syndrome and characteristics …

Abstract Study Objectives: To address whether treatment of sleep apnea improves glucose
tolerance. Design: Randomized, double-blind crossover study. Setting: Sleep clinic referrals …

Abstract Study Objectives: To determine associations between obstructive sleep apnea
(OSA) and neurocognitive performance in a large cohort of adults. Study Design: Cross …

Background: Previous randomized controlled trials have addressed the efficacy of
mandibular advancement devices (MADs) in the treatment of obstructive sleep apnea (OSA) …

Rationale: Dyslipidemia is common in Obstructive Sleep Apnea (OSA). Postprandial
lipidemia (PPL) is a strong marker of cardiovascular risk. Evidence that OSA treatment …

Objective: Small uncontrolled series suggest that treatment of obstructive sleep apnea (OSA)
in patients with epilepsy may improve seizure control. Prior to conducting a definitive …